Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Serdar Turhal
27 years of experience
accreditations :
Clinic is certified :
Immunotherapy with Keytruda (Pembolizumab) in Turkey typically costs from AUD $6,000 to AUD $10,600 per treatment cycle. The final price depends on the required dosage, the specific cancer type, and the medical hub chosen, such as Istanbul or Antalya. Patients save around 31% by travelling to Turkey from Australia, where this treatment costs AUD $8,800 on average. These fees generally cover the medication, infusion services, and oncology consultations.
Bookimed Expert Insight: Australian patients find exceptional value in Istanbul at clinics like Anadolu Medical Center. This facility is affiliated with Johns Hopkins Hospital (USA) and follows international ESMO protocols. Choosing such institutions ensures access to specialists like Professor Yesim Yildirim, who is ESMO-certified and holds over 20 years of experience. This combination of American-standard care and Turkish pharmaceutical pricing offers a significant financial advantage without compromising clinical excellence.
| Turkey | Thailand | South Korea | |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $6,000 | ≈ AUD $11,500 | ≈ AUD $7,500 |
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Serdar Turhal is a highly experienced oncologist specializing in medical oncology and chemotherapy for breast cancer at Anadolu Medical Center. He is a member of many international oncology associations and has authored numerous articles in international publications. He specializes in prognostic factors and the therapy of malignant gastrointestinal neoplasms. To receive a consultation from Dr. Turhal, please submit a request on Bookimed.
Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.
He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).
Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).
Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.